Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
32.98
-1.76 (-5.05%)
Mar 31, 2025, 10:13 AM EDT - Market open
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $3.07 billion as of March 31, 2025. Its market cap has decreased by -2.78% in one year.
Market Cap
3.07B
Enterprise Value
1.93B
1-Year Change
-2.78%
Ranking
Category
Stock Price
$32.98
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $3.07B, an increase of 444.09%. That is a compound annual growth rate of 28.77%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 722.87B |
| UnitedHealth Group | 477.35B |
| Johnson & Johnson | 398.56B |
| AbbVie | 366.28B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 229.08B |
| Merck & Co. | 224.67B |